Archive Newsletter
-
08.01.25 -- Biopharma Needs A Boost — Our Newest Podcast Has Ideas
8/1/2025
08/01/25
-
08.01.25 -- Redefining CGT With Exosomes And EVs
8/1/2025
08/01/25 Cell & Gene Newsletter
-
07.31.25 -- Is Your Pharma Facility Ready For The Next Public Health Crisis?
7/31/2025
07/31/25 Cell & Gene Newsletter
-
07.30.25 -- Audit Trail Compliance And What To Look For In Mitigation Software
7/30/2025
07/30/25 Cell & Gene Newsletter
-
07.29.25 -- STREAM Edition: Path To IND: AAV Transient Transfection, Producer Cell Line Platforms
7/29/2025
07/29/25 Cell & Gene Newsletter
-
07.29.25 -- Rethinking Large Animal Models In Gene Therapy With Novartis' Ralf Schmid, Ph.D.
7/29/2025
07/29/25 Cell & Gene Newsletter
-
07.28.25 -- A Flexible Mindset For Bridging Between Cell-Based Assay Groups
7/28/2025
07/28/25 Cell & Gene Newsletter
-
07.25.25 -- Unlocking Value In Biopharma Operations: A C-Suite Call To Action
7/25/2025
07/25/25 Cell & Gene Newsletter
-
07.24.25 -- Essential Steps For A Successful Analytical Tech Transfer
7/24/2025
07/24/25 Cell & Gene Newsletter
-
07.23.25 -- Redefining CGT With Exosomes And EVs
7/23/2025
07/23/25 Cell & Gene Newsletter